Abstract
A wide variety of drugs and other foreign compounds are dealkylated by enzyme systems localized in the microsomal fraction of liver and to lesser degrees, in kidney, lung, and other organs including placenta. During an investigation of the metabolism of a series of chemical carcinogens, Miller et al. (1952) observed that after the intraperitoneal administration of 3′-methyl-4-dimethyl-14C-amino-azobenzene to rats, a significant amount of 14CO2 was recoverable from the expired air. Subsequent work (Mueller and Miller, 1953) revealed the presence of an enzyme system in rat liver which catalyzed the demethylation of a number of secondary amines with the liberation of formaldehyde and primary amine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abramson, F.B., Furst, C.L., McMartin, C., Wade, R.: The isolation, identification and synthesis of two metabolites of guanethidine formed in pig and rabbit liver homogenates. Biochem. J. 113, 143–156 (1969).
Adler, T.K.: Studies on morphine tolerance in mice. I. In vivo N-demethylation of morphine and N-and O-demethylation of codeine. J. Pharmacol. exp. Ther. 156, 585–590 (1967).
Albert, J.R., Boxill, G.C., Weikel, J.H.: Anticonvulsant and toxicologic properties of some benzilic amides and the physiological disposition of the N-ethyl derivative. J. Pharmacol. exp. Ther. 131, 85–90 (1961).
Anders, M.W., Alvares, A.P., Mannering, G.J.: Inhibition of drug metabolism. II. Metabolism of 2-diethylaminoethyl 2,2-diphenylvalerate HCl (SKF 525-A). Molec. Pharmacol. 2, 328–334 (1966).
Axelrod, J.: The enzymatic deamination of amphetamine (Benzedrine). J. biol. Chem. 214, 753–763 (1955a).
Axelrod, J.: The enzymatic demethylation of ephedrine. J. Pharmacol. exp. Ther. 114, 430–438 (1955b).
Axelrod, J.: The enzymatic conversion of codeine to morphine. J. Pharmacol. exp. Ther. 115, 259–267 (1955c).
Axelrod, J.: The enzymic cleavage of aromatic ethers. Biochem. J. 63, 634–639 (1956a).
Axelrod, J.: The enzymatic N-demethylation of narcotic drugs. J. Pharmacol. exp. Ther. 117, 322–330 (1956b).
Axelrod, J., Cochin, J.: The inhibitory action of nalorphine on the enzymatic N-demethylation of narcotic drugs. J. Pharmacol. exp. Ther. 121, 107–112 (1957).
Baker, J.R., Chaykin, S.: The biosynthesis of trimethylamine-N-oxide. J. biol. Chem. 237, 1309–1313 (1962).
Beckett, A.H., Beaven, M.A., Robinson, A.E.: Metabolism of chlorpromazine in humans. Biochem. Pharmacol. 12, 779–794 (1963).
Bickel, M.H.: The pharmacology and biochemistry of N-oxides. Pharmacol. Rev. 21, 325–355 (1969).
Bickel, M.H., Baggiolini, M., The metabolism of imipramine and its metabolites by rat liver microsomes. Biochem. Pharmacol. 15, 1155–1169 (1966).
Bickel, M.H., Flückinger, M., Baggiolini, M.: Vergleichende Demethylierung von tricyclischen Psychopharmaka durch Rattenlebermikrosomen. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 256, 360–366 (1967).
Brodie, B.B., Gillette, J.R., La Du, B.N.: Enzymatic metabolism of drugs and other foreign compounds. Ann. Rev. Biochem. 27, 427–454 (1958).
Brodie, B.B., Maickel, R.P.: Comparative biochemistry of drug metabolism. In: Proceedings of the First International Pharmacological Meeting. Ed. by B.B. Brodie and E. G. Erdos. Vol. 6, pp. 299–324. New York: MacMillan 1962.
Buhler, D.R., Rasmusson, M.E.: The oxidation of drugs by fishes. Comp. Biochem. Physiol. 25, 223–239 (1968).
Butler, T.C., Waddell, W.J.: The metabolic fate of 5-ethyl-l-methyl-5-phenyl hydantoin (1-methylnirvanol) and that of 3,5-diethyl-5-phenyl hydantoin (3-ethylnirvanol). J. Pharmacol. exp. Ther. 127, 171–174 (1959).
Butler, T.C., Waddell, W.J., Poole, D.T.: Demethylation of trimethadione and metharbital by rat liver microsomal enzymes. Biochem. Pharmacol. 14, 937–942 (1965).
Chakraborty, J., Smith, J.N.: Enzymic oxidation of some alkylbenzenes in insects and vertebrates. Biochem. J. 102, 498–503 (1967).
Chaykin, S., Dagani, M., Johnson, L., Samli, M.: The fate of nicotinamide in the mouse: urinary metabolites. J. biol. Chem. 240, 932–938 (1965).
Coccia, P.F., Westerfeld, W.W.: The metabolism of chlorpromazine by liver microsomal enzyme systems. J. Pharmacol. exp. Ther. 157, 446–458 (1967).
Conney, A.H.: Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19, 317–366 (1967).
Cooper, D.Y., Levin, S., Narasimhulu, S., Rosenthal, O., Estabrook, R.W.: Photochemical action spectrum of the terminal oxidase of mixed function oxidase systems. Science 147, 400–02 (1965).
Creaven, P.J., Davies, W.H., Williams, R.T.: Dealkylation of alkoxybiphenyls by trout and frog liver preparations. Life Sci. 6, 105–111 (1967).
Davies, D.S., Gigon, P.L., Gillette, J.R.: Sex differences in the kinetic constants for the N-demethylation of ethylmorphine by rat liver microsomes. Biochem. Pharmacol. 17, 1865–1872 (1968).
Davies, W.H., Creaven, P.J.: The effect of carcinogenic and noncarcinogenic compounds on the O-dealkylating activity of the hepatic microsomal enzyme system of the rat. Biochem. Pharmacol. 16, 1839–1845 (1967).
Degkwitz, E., Ullrich, V., Staudinger Hj.: Metabolism and cytochrome P-450 binding spectra of (+) and (−) hexobarbital in rat liver microsomes. Hoppe-Seylers Z. physiol. Chem. 350, 547–553 (1969).
Dewaide, J.H., Henderson, P.T.: Hepatic N-demethylation of aminopyrine in rat and trout. Biochem. Pharmacol. 17, 1901–1907 (1968).
Dingell, J.V.: Personal communication (1970).
Dingell, J.V., D’Encarnacao, P.W.: Studies on the demethylation of secondary and tertiary amines. Pharmacologist 8, 181 (1966).
Dingell, J.V., Sulser, F., Gillette, J.R.: Species differences in metabolism of impramine and desmethylimipramine. J. Pharmacol. exp. Ther. 143, 14–22 (1964).
Elison, C., Elliot, H.W.: Studies on the enzymatic N-and O-demethylation of narcotic analogesics and evidence for the formation of codeine from morphine in rats and dogs. J. Pharmacol. exp. Ther. 144, 265–275 (1964).
Elison, C., Elliot, H.W., Look, M., Rapoport, H.: Some aspects of the fate and relationship of the N-methyl group of morphine to its pharmacological activity. J. med. pharm. Chem. 6, 237–246 (1963).
Elison, C., Rapaport, H., Laursen, R., Elliot, H.W.: Effect of deuteration of N-CH3 group on potency and enzymatic N-demethylation of morphine. Science 134, 1078–1079 (1961).
Emmerson, J.L., Anderson, R.C.: Metabolism of trifluralin in the rat and dog. Toxicol. appl. Pharmacol. 9, 84–97 (1966).
Fishman, V., Goldenberg, H.: Identification of a new metabolite of imipramine. Proc. Soc. exp. Biol. (N.Y.) 110, 187–190 (1962).
Fishman, V., Heaton, A., Goldenberg, H.: Metabolism of chlorpromazine. III. Isolation and identification of chlorpromazine-N-oxide. Proc. Soc. exp. Biol. (N.Y.) 109, 548–552 (1962).
Foreman, R.L. Siegel F.P., Mrtek, R.G.: Synthesis of deuterio-l-amphetamine, d, sulfate. J. pharm. Sci. 58, 189–192 (1969).
Frear, D.S.: Microsomal N-demethylation, by a cotton leaf oxidase system, of 3-(4′-chlorophenyl)-1,1-dimethylurea (Monuron). Science 162, 674–675 (1968).
Furner, R.L., McCarthy, J.S., Stitzel, R.E., Anders, M.W.: Stereoselective metabolism of the enantiomers of hexobarbital. J. Pharmacol. exp. Ther. 169, 153–158 (1969).
Gaudette, L.E., Brodie, B.B.: Relationship between the lipid solubility of drugs and their oxidation by liver microsomes. Biochem. Pharmacol. 2, 89–96 (1959).
Gillette, J.R.: Biochemistry of drug oxidation and reduction by enzymes in hepatic endoplasmic reticulum. In: Advances in Pharmacology, vol. 4, pp. 219–261. Ed. by S. Garattini and P.A. Shore. New York: Academic Press 1966.
Gillette, J.R., Dingell, J.V., Sulser, F., Kuntzman, R., Brodie, B.B.: Isolation from rat brain of a metabolic product, desmethylimipramine, that mediates the antidepressant activity of imipramine. Experientia (Basel) 17, 377–381 (1961).
Gram, T.E., Wilson, J.T., Fouts, J.R.: Some characteristics of hepatic microsomal systems which metabolize aminopyrine in the rat and rabbit. J. Pharmacol. exp. Ther. 159, 172–181 (1968).
Guarino, A.M., Conway, W.D., Fales, H.M.: Mass spectral identification of probenecid metabolites in rat bile. Europ. J. Pharmacol. 8, 244–252 (1969).
Henderson, J.F., Mazel, P.: Studies of the induction of microsomal S-, N-, and O-demethylases. Biochem. Pharmacol. 13, 1471–1474 (1964).
Hespe, W., de Roos, A.M., Nauta, W.T.: Investigation into the metabolic fate of orphenadrene hydrochloride after oral administration to male rats. Arch. int. Pharmacodyn. 156, 180–200 (1965).
Huggins, C., Jensen, E.V., Cleveland, A.S.: On phenyletherase. Proc. Soc. exp. Biol. (N.Y.) 68, 477–480 (1948).
Kamm, J.J., Ferullo, C.R., Miller, D., Van Loon, E.J.: Metabolism of chlorpheniramine-3H by the rat and dog. Biochem. Pharmacol. 18, 659–671 (1969).
Kamm, J.J., Taddeo, A.B., van Loon, E.J.: Metabolism and excretion of tritiated dextromethorphan by the rat. J. Pharmacol. exp. Ther. 158, 437–444 (1967).
Kato, R., Gillette, J.R.: Effect of starvation on NADPH-dependent enzymes in liver microsomes of male and female rats. J. Pharmacol. exp. Ther. 150, 279–284 (1965).
Klutch, A., Bordun, M.: Metabolic fate of methoxamine and N-isopropylmethoxamine. J. med. pharm. Chem. 10, 860–863 (1967).
Koe, B.K., Pinson, R.: Isolation and characterization of urinary metabolites of benzquinamide and benzquinamide alcohol. J. med. pharm. Chem. 7, 635–640 (1964).
Kratz, F., Staudinger, Hj.: Zur Frage der Induzierbarkeit mikrosomaler Enzyme am Beispiel der Cumarinhydroxylierung in der Kaninchenleber. Hoppe-Seylers Z. physiol. Chem. 348, 568–574 (1967).
Kuntzman, R., Klutch, A., Tsai, I., Burns, J.J.: Physiological distribution and metabolic inactivation of chlorcyclizine and cyclizine. J. Pharmacol. exp. Ther. 149, 29–35 (1965).
Kuntzmann, R., Phillips, A., Tsai, I., Klutch, A., Burns, J.J.: N-Oxide formation: A new route for inactivation of the antihistaminic chlorcyclizine. J. Pharmacol. exp. Ther. 155, 337–344 (1967).
La Du, B.N., Gaudette, L., Trousof, N., Brodie, B.B.: Enzymatic dealkylation of aminopyrine (Pyramidon) and other alkylamines. J. biol. Chem. 214, 741–752 (1955).
Leadseater, L., Davies, D.R.: The inhibition of the liver microsomal N-demethylation of morphine by N-allylnormorphine and its pharmacological implications. Biochem. Pharmacol. 13, 1569–1576 (1964).
Lin, S.C.C., Way, E.L.: N-dealkylation of anileridine to normeperidine. J. Pharmacol. exp. Ther. 150, 309–315 (1965).
Lu, A.Y.H., Junk, K.W., Coon, M.J.: Resolution of the cytochrome P-450 containing ω-hydroxylation system of liver microsomes into three components. J. biol. Chem. 244, 3714–3721 (1969).
Machinist, J.M., Orme-Johnson, W.H., Ziegler, D.M.: Microsomal oxidases. II. Properties of a pork liver microsomal N-oxide dealkylase. Biochemistry 5, 2939–2943 (1966).
Mannering, G.J., Schanker, L.S.: Metabolic fate of levo-3-hydroxy-N-alkylmorphinan (levallophan). J. Pharmacol. exp. Ther. 124, 296–304 (1958).
Mao, J.C.H., Tardrew, P.L.: Demethylation of erythromycins by rabbit tissue in vitro. Biochem. Pharmacol. 14, 1049–1058 (1965).
Mazel, P.: Personal communication (1969).
Mazel, P., Henderson, J.F., Axelrod, J.: S-demethylation by microsomal enzymes. J. Pharmacol. exp. Ther. 143, 1–6 (1964).
Mazel, P., Kerza-Kwiatecki, A., Simanis, J.: Studies on the demethylation of puromycin and related compounds by liver microsomal enzymes. Biochim. biophys. Acta (Amst.) 114, 72–82 (1966).
McMahon, R.E.: The metabolism of 2-(butylaminomethyl)-1,4-benzodioxane-14C. J. Amer. chem. Soc. 81, 5199–5201 (1959).
McMahon, R.E.: The metabolism of chlorethoxybutamoxane-14C. J. Pharmacol. exp. Ther. 130, 383–388 (1960).
McMahon, R.E.: The competitive inhibition of the N-demethylation of butynamine by 2,4-dichloro-6-phenylphenoxyethylamine (DPEA). J. Pharmacol. exp. Ther. 138, 382–386 (1962).
McMahon, R.E.: The demethylation in vitro of N-methyl barbiturates and related compounds by mammalian liver microsomes. Biochem. Pharmacol. 12, 1225–1228 (1963).
McMahon, R.E.: Some observations on the in vitro demethylation of secondary N-methyl amines by liver microsomes. Life Sci. 3, 235–241 (1964).
McMahon, R.E.: Microsomal dealkylation of drugs: substrate specificity and mechanism. J. pharm. Sci. 55, 457–466 (1966).
McMahon, R.E., Culp, H.W., Marshall, F.J.: The metabolism of a-dl-acetylmethadol in the rat. The identification of the probable active metabolite. J. Pharmacol. exp. Ther. 149, 436–445 (1965).
McMahon, R.E., Culp, H.W., Mills, J., Marshall, F.J.: Demethylation studies. IV. The in vitro and in vivo cleavage of alkyl and arylalkyl-p-nitrophenyl ethers. J. med. pharm. Chem. 6, 343–346 (1963a).
McMahon, R.E., Culp, H.W., Occolowitz, J.C.: Studies on the hepatic microsomal N-dealkylation reaction. Molecular oxygen as the source of the oxygen atom. J. Amer. chem. Soc. 91, 3389–3390 (1969).
McMahon, R.E., Marshall, F.J., Culp, H.W., Miller, W.M.: The metabolism of nortriptyline-N-methyl-14C in rats. Biochem. Pharmacol. 12, 1207–1217 (1963b).
McMahon, R.E., Sullivan, H.R.: The oxidative demethylation of l-propoxyphene and l-propoxyphene-N-oxide by rat liver microsomes. Life Sci. 3, 1167–1174 (1964).
McMahon, R.E., Welles, J.S., Lee, H.M.: The metabolism of benzodioxane derivatives. II. Ethoxybutamoxane-14C. J. Amer. chem. Soc. 82, 2864–2866 (1960).
Miller, E.C., Plescia, A.M., Miller, J.A., Heidelberger, C.: The metabolism of methylated aminoazo dyes. I. The demethylation of 3′-methyl-4-dimethyl-14C-aminoazobenzene in vivo. J. biol. Chem. 196, 863–874 (1952).
Mitoma, C., Yasuda, D.M., Tagg, J., Tanabe, M.: Effect of deuteration of the O-CH3 group on the enzymic demethylation of o-nitroanisole. Biochim. biophys. Acta (Amst.) 136, 566–567 (1967).
Mueller, G.C., Miller, J.A.: The metabolism of methylated aminoazo dyes. II. Oxidative demethylation by rat liver homogenates. J. biol. Chem. 202, 579–587 (1953).
Mule, S.J., Clements, T.H., Gorodetzky, C.W.: The metabolic fate of 3H-cyclazocine in dogs. J. Pharmacol. exp. Ther. 160, 387–396 (1968).
Narrod, S.A., Wilk, A.L., King, C.T.G.: Metabolism of meclizine in the rat. J. Pharmacol. exp. Ther. 147, 380–384 (1965).
Neely, W.B.: The metabolic fate of formaldehyde-14C intraperitoneally administered to the rat. Biochem. Pharmacol. 13, 1137–1142 (1964).
Netter, K.J., Seidel, G.: An adaptively stimulated O-demethylating system in rat liver microsomes and its kinetic properties. J. Pharmacol. exp. Ther. 146, 61–65 (1964).
Pettit, F.H., Ziegler, D.M.: The catalytic demethylation of N,N-dimethylanilme-N-oxide by liver microsomes. Biochem. biophys. Res. Commun. 13, 193–197 (1963).
Renson, J., Weissbach, H., Udenfriend, S.: On the mechanism of oxidative cleavage of aryl-alkyl ethers by liver microsomes. Molec. Pharmacol. 1, 145–148 (1965).
Sarcione, E.J., Stutzman, L.: A comparison of the metabolism of 6-mercaptopurine and its 6-methyl analog in the rat. Cancer Res. 20, 387–392 (1960).
Schenkman, J.B., Frey, I., Remmer, H., Estabrook, R.W.: Sex differences in drug metabolism by rat liver microsomes. Molec. Pharmacol. 3, 516–525 (1967).
Schreiber, E.C., Min, B.H., Zeiger, A.V., Long, J.F.: Metabolism of diethylpropion-1-14C hydrochloride by the human. J. Pharmacol. exp. Ther. 159, 372–378 (1968).
Schwartz, M.A., Koechlin, B.A., Postma, E., Palmer, S., Krol, G.: Metabolism of diazepam in rat, dog, and man. J. Pharmacol. exp. Ther. 149, 423–435 (1965).
Schwartz, M.A., Postma, E.: Metabolic N-demethylation of chlordiazepoxide. J. pharm. Sci. 55, 1358–1362 (1966).
Sladek, N.E., Mannering, G.J.: Induction of drug metabolism. Molec. Pharmacol. 5, 174–185 (1969).
Smith, D.L., Keasling, H.H., Forist, A.A.: The metabolism of N-alkyl-4-bromobenzenesulfonamides in the mouse. J. med. pharm. Chem. 8, 520–524 (1965).
Smith, J.N.: Detoxication mechanisms. Ann. Rev. Entomol. 7, 465–480 (1962).
Symchowicz, S., Wong, K.K.: Metabolism of griseofulvin-14C; studies in vivo. Biochem. Pharmacol. 15, 1595–1600 (1966a).
Symchowicz, S., Wong, K.K.: Metabolism griseofulvin-14C; studies in vitro. Biochem. Pharmacol. 15, 1601–1606 (1966b).
Takemori, A.E., Mannering, G.J.: Metabolic N-and O-demethylation of morphine-and morphinan-type analgesics. J. Pharmacol. exp. Ther. 123, 171–179 (1958).
Vree, T.B., Van Rossum, J.M.: Kinetics of metabolism and excretion of amphetamines in man. In: International Symposium on Amphetamines and Related Compounds. Eds. E. Costa and S. Garattini, pp. 165–190. New York: Raven Press 1970.
Welles, J.S., Root, M.A., Anderson, R.C.: Urinary metabolites of chlorpropamide in dogs, rabbits and man. Proc. Soc. exp. Biol. (N.Y.) 101, 668–671 (1959).
Wiberg, K.B.: The deuterium isotope effect. Chem. Rev. 55, 713–743 (1955).
Ziegler, D.M., Pettit, F.H.: Formation of an intermediate N-oxide in the oxidative demethylation of N,N-dimethylaniline catalyzed by liver microsomes. Biochem. biophys. Res. Commun. 15, 188–193 (1964).
Ziegler, D.M., Pettit, F.H.: Microsomal oxidases. I. The isolation and dialkylarylamine oxygenase activity of pork liver microsomes. Biochemistry 5, 2932–2938 (1966).
Zins, G.R.: The in vivo production of a potent long-acting hypotensive metabolite from diallylmelamine. J. Pharmacol. exp. Ther. 150, 109–117 (1965).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Gram, T.E. (1971). Enzymatic N-, O-, and S-Dealkylation of Foreign Compounds by Hepatic Microsomes. In: Brodie, B.B., Gillette, J.R., Ackerman, H.S. (eds) Concepts in Biochemical Pharmacology. Handbook of Experimental Pharmacology / Handbuch der experimentellen Pharmakologie, vol 28 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65177-9_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-65177-9_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65179-3
Online ISBN: 978-3-642-65177-9
eBook Packages: Springer Book Archive